Back to SYRE
PERCEPTIVE ADVISORS LLC → SYRE
PERCEPTIVE ADVISORS LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$292.1M
Q3 2026
Peak value
$383.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $100.5M |
| Q1 2026 | $190.8M |
| Q1 2026 | $190.8M |
| Q2 2026 | $383.5M |
| Q3 2026 | $292.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $292.1M | 3.28M | — | — |
| Q2 2026 | $383.5M | 4.32M | — | — |
| Q1 2026 | $190.8M | 3.78M | — | — |
| Q1 2026 | $190.8M | 3.78M | — | — |
| Q4 2025 | $100.5M | 3.07M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$377.5M
$348.1M